ClinVar Miner

Submissions for variant NM_000231.3(SGCG):c.800_801del (p.Cys267fs)

dbSNP: rs780348174
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000667789 SCV000792293 likely pathogenic Autosomal recessive limb-girdle muscular dystrophy type 2C 2017-06-13 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001200356 SCV001371292 pathogenic not provided 2020-06-01 criteria provided, single submitter clinical testing
Invitae RCV000667789 SCV002238294 pathogenic Autosomal recessive limb-girdle muscular dystrophy type 2C 2023-04-14 criteria provided, single submitter clinical testing ClinVar contains an entry for this variant (Variation ID: 552513). This variant is also known as ∆801–TC. This frameshift has been observed in individual(s) with limb-girdle muscular dystrophy (PMID: 8923014, 24638197). This variant is present in population databases (rs780348174, gnomAD 0.01%). This sequence change results in a frameshift in the SGCG gene (p.Cys267Serfs*51). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 25 amino acid(s) of the SGCG protein and extend the protein by 25 additional amino acid residues. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Cys283 amino acid residue in SGCG. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8968757, 22095924). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing.
Baylor Genetics RCV000667789 SCV004201044 pathogenic Autosomal recessive limb-girdle muscular dystrophy type 2C 2023-08-09 criteria provided, single submitter clinical testing
OMIM RCV000667789 SCV000022242 pathogenic Autosomal recessive limb-girdle muscular dystrophy type 2C 1996-11-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.